Enliven Therapeutics CMO Helen Louise Collins disposes of USD 250,000 in common shares

Bitget2026/09/21 21:22

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Enliven Therapeutics Chief Medical Officer Helen Louise Collins exercised stock options for 5,000 shares at $2.48 on Sept. 17, 2026.
Collins sold 5,000 shares the same day at weighted average prices of $50.03, $50.71, and $51.48.
Beneficial ownership in common stock ended at 25,000 shares following the transactions.
Derivative holdings show 106,268 stock options remaining after the exercise.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Enliven Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001701247-26-000013), on September 21, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Enliven Therapeutics CMO Helen Louise Collins disposes of USD 250,000 in common shares

You may also like

Crypto prices